Dmytro Yaremko

Recent publications · Crossref

5 total works indexed

1. Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

   · 2008 · cited 3,143x

2. Advances in molecular quantum chemistry contained in the Q-Chem 4 program package

   · 2014 · cited 2,829x

3. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,788x

4. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,873x

5. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

   · 2019 · cited 1,619x

via Crossref · CC0